Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.
Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Jones SA, Mofenson LM, Contag CH, Bassett M, Katzenstein DA; HIVNET 023 Study Team. Lee EJ, et al. Among authors: kantor r. J Infect Dis. 2005 Oct 1;192(7):1260-4. doi: 10.1086/444424. Epub 2005 Aug 23. J Infect Dis. 2005. PMID: 16136470 Clinical Trial.
HIV-2 diagnosis and quantification in high-risk patients.
Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R. Chan PA, et al. Among authors: kantor r. AIDS Res Ther. 2008 Aug 14;5:18. doi: 10.1186/1742-6405-5-18. AIDS Res Ther. 2008. PMID: 18700986 Free PMC article.
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories.
Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M; TAQAS Laboratory Network. Land S, et al. Among authors: kantor r. J Virol Methods. 2009 Aug;159(2):185-93. doi: 10.1016/j.jviromet.2009.03.016. Epub 2009 Mar 26. J Virol Methods. 2009. PMID: 19490972 Free PMC article.
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings.
Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, Mayer KH, Benson C, Schooley R. Kumarasamy N, et al. Among authors: kantor r. Clin Infect Dis. 2009 Jul 15;49(2):306-9. doi: 10.1086/600044. Clin Infect Dis. 2009. PMID: 19522657 Free PMC article.
305 results